[1]
D. Bunger, A. Rajani, L. Patel, and S. Sharma, “Real-world use and acceptance of biosimilar rituximab in oncology practice in India”, Int J Adv Med, vol. 9, no. 11, pp. 1096–1101, Oct. 2022.